BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 18, 2012
View Archived Issues
Genetic alterations linked to immune function dysregulation with cold urticaria
Read More
New hepatitis C virus NS5A inhibitor identified and characterized
Read More
Full results published of phase III breast cancer study CLEOPATRA
Read More
Researchers at Novartis present new insulin-like growth factor 1 receptor antagonists
Read More
U.S. team designs novel series of antibacterial agents
Read More
Ardea Biosciences discloses new inhibitors of urate transport
Read More
Novel agents for HIV infection synthesized in Korea
Read More
One-pot cascade synthesis yields modulators of centrosome integrity
Read More
New muscarinic acetylcholine M1 receptor positive allosteric modulators patented
Read More
Roche technology used to identify mutations underlying hearing loss
Read More
Idenix Pharmaceuticals provides update on agents for hepatitis C
Read More
Lunesta approved for Japanese market
Read More
Gilead Sciences completes acquisition
Read More
DARA BioSciences announces acquisitions
Read More
Medivation and Pfizer report data from phase III CONCERT trial
Read More
Ranmark approved in Japan
Read More
Takeda's Azilva approved in Japan
Read More
Niiki Pharma completes first-in-human trial of anticancer agent
Read More
Pevion reports encouraging data on PEV-7 for recurrent vulvovaginal candidiasis
Read More
FDA approves new product for methotrexate poisoning due to impaired renal function
Read More
Abilify approved for new indication in Japan
Read More
OxiFast approved in Japan for cancer pain
Read More
Xarelto approved in Japan for prevention of stroke and systemic embolism in patients with AF
Read More
Phase II tivantinib study in second-line hepatocellular carcinoma meets primary endpoint
Read More
Regnite approved in Japan for restless legs syndrome
Read More